BlackRock Fund Advisors’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$19.3M Buy
314,753
+46,875
+17% +$3.05M ﹤0.01% 2203
2016
Q3
$18.5M Buy
267,878
+11,596
+5% +$765K ﹤0.01% 2112
2016
Q2
$14.3M Sell
256,282
-4,184
-2% -$252K ﹤0.01% 2213
2016
Q1
$15.8M Sell
260,466
-26,068
-9% -$1.53M ﹤0.01% 2103
2015
Q4
$18.3M Buy
286,534
+10,322
+4% +$669K ﹤0.01% 2104
2015
Q3
$18.5M Sell
276,212
-1,634
-0.6% -$116K ﹤0.01% 2038
2015
Q2
$19M Sell
277,846
-22,194
-7% -$1.41M ﹤0.01% 2144
2015
Q1
$16.7M Buy
300,040
+4,346
+1% +$223K ﹤0.01% 2166
2014
Q4
$15.2M Buy
295,694
+33,578
+13% +$1.65M ﹤0.01% 2221
2014
Q3
$9.65M Sell
262,116
-25,270
-9% -$912K ﹤0.01% 2366
2014
Q2
$11.2M Sell
287,386
-16,160
-5% -$600K ﹤0.01% 2352
2014
Q1
$11.4M Buy
303,546
+6,814
+2% +$238K ﹤0.01% 2323
2013
Q4
$11.2M Sell
296,732
-13,342
-4% -$511K ﹤0.01% 2327
2013
Q3
$13.5M Buy
310,074
+37,356
+14% +$1.5M ﹤0.01% 2184
2013
Q2
$9.87M Buy
+272,718
New +$8.29M ﹤0.01% 2269

Other funds holding USNA

BlackRock Fund Advisors's USNA Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Usana Health Sciences (USNA) stake by 17% in Q4 2016, buying an estimated $3.05M and bringing the position to 314,753 shares worth $19.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2203.

BlackRock Fund Advisors first reported a position in USNA in Q2 2013 and has held it in 15 quarters since. 149 funds tracked by Wall St. Rank hold USNA as of Q4 2016.

  • BlackRock Fund Advisors held 314,753 shares of Usana Health Sciences worth $19.3M as of Q4 2016.
  • BlackRock Fund Advisors bought 46,875 Usana Health Sciences shares in Q4 2016, an estimated $3.05M.
  • Usana Health Sciences made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2203 holding.
  • BlackRock Fund Advisors first reported a position in Usana Health Sciences in Q2 2013 and has held it in 15 quarters since.
  • 149 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.